These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12217602)

  • 1. Infection of HepG2 cells with recombinant adenovirus encoding the HCV core protein induces p21(WAF1) down-regulation -- effect of transforming growth factor beta.
    Dubourdeau M; Miyamura T; Matsuura Y; Alric L; Pipy B; Rousseau D
    J Hepatol; 2002 Oct; 37(4):486-92. PubMed ID: 12217602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells.
    Miyazaki M; Sakaguchi M; Akiyama I; Sakaguchi Y; Nagamori S; Huh NH
    Cancer Res; 2004 Jun; 64(12):4155-61. PubMed ID: 15205326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta 1 stimulates or inhibits cell growth via down- or up-regulation of p21/Waf1.
    Miyazaki M; Ohashi R; Tsuji T; Mihara K; Gohda E; Namba M
    Biochem Biophys Res Commun; 1998 May; 246(3):873-80. PubMed ID: 9618305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of p53 tumor suppressor by hepatitis C virus core protein.
    Lu W; Lo SY; Chen M; Wu Kj; Fung YK; Ou JH
    Virology; 1999 Nov; 264(1):134-41. PubMed ID: 10544138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus core protein down-regulates p21(Waf1/Cip1) and inhibits curcumin-induced apoptosis through microRNA-345 targeting in human hepatoma cells.
    Shiu TY; Huang SM; Shih YL; Chu HC; Chang WK; Hsieh TY
    PLoS One; 2013; 8(4):e61089. PubMed ID: 23577194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
    Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
    Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced p21(WAF1/CIP1) protein expression is predominantly related to altered p53 in hepatocellular carcinomas.
    Shi YZ; Hui AM; Takayama T; Li X; Cui X; Makuuchi M
    Br J Cancer; 2000 Jul; 83(1):50-5. PubMed ID: 10883667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus core protein represses p21WAF1/Cip1/Sid1 promoter activity.
    Ray RB; Steele R; Meyer K; Ray R
    Gene; 1998 Feb; 208(2):331-6. PubMed ID: 9524287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus core protein selectively inhibits synthesis and accumulation of p21/Waf1 and certain nuclear proteins.
    Oka K; Nagano-Fujii M; Yoshida I; Hidajat R; Deng L; Akutsu M; Hotta H
    Microbiol Immunol; 2003; 47(6):429-38. PubMed ID: 12906103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional repression of p21(waf1) promoter by hepatitis B virus X protein via a p53-independent pathway.
    Ahn JY; Chung EY; Kwun HJ; Jang KL
    Gene; 2001 Sep; 275(1):163-8. PubMed ID: 11574165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
    Park US; Park SK; Lee YI; Park JG; Lee YI
    Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of hepatitis B virus X gene on p21(WAF1) expression through p53-dependent and p53-independent pathways].
    Lin J; Zhu MH; Qu JH; Li FM; Ni CR
    Ai Zheng; 2004 Jul; 23(7):749-55. PubMed ID: 15248906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.
    Gong J; Ammanamanchi S; Ko TC; Brattain MG
    Cancer Res; 2003 Jun; 63(12):3340-6. PubMed ID: 12810668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus core protein represses the p21 promoter through inhibition of a TGF-beta pathway.
    Lee MN; Jung EY; Kwun HJ; Jun HK; Yu DY; Choi YH; Jang KL
    J Gen Virol; 2002 Sep; 83(Pt 9):2145-2151. PubMed ID: 12185267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of p21/Waf1/Cip1/Sdi1 expression by hepatitis C virus core protein.
    Yoshida I; Oka K; Hidajat R; Nagano-Fujii M; Ishido S; Hotta H
    Microbiol Immunol; 2001; 45(10):689-97. PubMed ID: 11762751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cyclin-dependent kinase inhibitor (p21(WAF1/CIP1)) affects thymidine incorporation in human liver cancer cells.
    Gong Y; Deng S; Zhang M; Wang G; Minuk GY; Burczynski F
    Br J Cancer; 2002 Feb; 86(4):625-9. PubMed ID: 11870547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells.
    Ala-aho R; Grénman R; Seth P; Kähäri VM
    Oncogene; 2002 Feb; 21(8):1187-95. PubMed ID: 11850838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WAF1/p21 regulates proliferation, but does not mediate p53-dependent apoptosis in urothelial carcinoma cell lines.
    Makri D; Schulz WA; Grimm M; Clasen S; Bojar H; Schmitz-Dräger BJ
    Int J Oncol; 1998 Mar; 12(3):621-8. PubMed ID: 9472102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
    Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
    Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
    Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
    Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.